Nanalysis Scientific Corp.
NSCIF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $9,285 | $9,576 | $10,594 | $12,289 |
| % Growth | -3% | -9.6% | -13.8% | – |
| Cost of Goods Sold | $7,256 | $7,251 | $7,878 | $8,104 |
| Gross Profit | $2,029 | $2,325 | $2,716 | $4,185 |
| % Margin | 21.9% | 24.3% | 25.6% | 34.1% |
| R&D Expenses | $89 | $136 | $143 | $104 |
| G&A Expenses | $2,083 | $2,513 | $2,401 | $2,148 |
| SG&A Expenses | $2,282 | $3,043 | $2,779 | $2,660 |
| Sales & Mktg Exp. | $199 | $530 | $378 | $512 |
| Other Operating Expenses | $830 | $987 | $859 | $1,086 |
| Operating Expenses | $3,201 | $4,166 | $3,781 | $3,850 |
| Operating Income | -$1,172 | -$1,841 | -$1,065 | $335 |
| % Margin | -12.6% | -19.2% | -10.1% | 2.7% |
| Other Income/Exp. Net | -$312 | -$315 | -$189 | -$7,814 |
| Pre-Tax Income | -$1,484 | -$2,156 | -$1,254 | -$7,479 |
| Tax Expense | $16 | -$34 | $53 | -$27 |
| Net Income | -$1,500 | -$2,122 | -$1,307 | -$7,452 |
| % Margin | -16.2% | -22.2% | -12.3% | -60.6% |
| EPS | -0.01 | -0.019 | -0.01 | -0.066 |
| % Growth | 46.5% | -87% | 84.8% | – |
| EPS Diluted | -0.01 | -0.02 | -0.01 | -0.066 |
| Weighted Avg Shares Out | 114,824 | 113,541 | 113,224 | 113,224 |
| Weighted Avg Shares Out Dil | 114,824 | 113,541 | 113,224 | 113,224 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $248 | $359 | $327 | $293 |
| Depreciation & Amortization | $883 | $1,051 | $924 | $1,155 |
| EBITDA | -$353 | -$790 | -$3 | -$6,031 |
| % Margin | -3.8% | -8.2% | -0% | -49.1% |